Dr. Rosa Kimura

Oncology pharmacist · Christie NHS Foundation Trust · United Kingdom (GB) · Oncology

Tier 2STK-0072GoodOwner MSL MTMei Tanaka

Data minimisation

Consent status: Recorded. The name shown may be a pseudonym. Contact details, personal identifiers and remuneration fields are hidden for your role; only scientific-profile fields needed for engagement planning are displayed.

Specialty: Thoracic oncology
Disease interests: SCLC, NSCLC
Scientific interests: PD-L1 biomarkersBrain metastases
Engagement preference: In person
Advisory boards: 1
Publications: 52
Source system: Veeva CRM
Data quality: Good

Engagement plan

Cadence target for Tier 2: 2 per year (assumption)

Last engaged: 07 Aug 2026 (39 days ago)
Next planned contact: 06 Feb 2027
Last 6 months vs target: 100%
2 of 1 expected engagements

Insights from this stakeholder (0)

No insights captured from engagements with this stakeholder.

Engagement history (2)

All engagements including drafts, newest first

Date	Type	Format	MSL	Product	Topics	Insights	Flags	Status
07 Aug 2026	Scientific exchange	Phone	Mei Tanaka	Vantrexa	Comparator checkpoint monotherapyElderly / ECOG 2 patients+1	0	—	Reviewed	ENG-0099
29 May 2026	Congress meeting	In person	Mei Tanaka	Vantrexa	PD-L1 testing turnaroundDuration of response+1	0	—	Reviewed	ENG-0115

Timeline

07 Aug 2026
Scientific exchange
Comparator checkpoint monotherapy, Elderly / ECOG 2 patients, Duration of response
29 May 2026
Congress meeting
PD-L1 testing turnaround, Duration of response, Elderly / ECOG 2 patients

Related stakeholders (6)

Christie NHS Foundation Trust

Dr. Sven Meyer
Radiation oncologist
Tier 2
Dr. Ulrich Hayashi
Renal pathologist
Tier 2
Dr. Zoë Meyer
Community nephrologist
Tier 2
Dr. Javier Zimmermann
Community nephrologist
Tier 2
Dr. Liam Jensen
Renal pathologist
Tier 1
Dr. Gabriel Yamamoto
Academic nephrologist
Tier 1